Search results
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks· 4 days agoFree Report) were down 4.4% on May 10 after the company announced that the FDA has delayed the review timeline for its mRNA-based, respiratory syncytial virus (RSV) vaccine, mRNA-1345.
Is Moderna Inc (MRNA) Set to Underperform? Analyzing the Factors
Guru Focus· 2 days agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
FDA delays decision on Moderna's RSV shot until the end of May
FierceBiotech· 6 days agoModerna will have to consider that after receiving word that the FDA will not meet a May 12 decision...
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 1 day agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
Trending: Moderna's Proposed RSV Vaccine Faces Delayed FDA Review
Morningstar· 6 days ago13:53 ET -- Moderna is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. The company said that the U.S ...
Moderna to Present at Upcoming Conferences in May/June 2024
The Joplin Globe· 3 days agoA replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation. Moderna is a leader in the creation of the ...
15 Black Scientists That Changed Our Understanding Of The World
AfroTech via Yahoo News· 3 hours agoThe work and pioneering done by Black Americans has historically gone unrecognized across many...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 3 days agoProofPilot, the industry's premier platform for patient & site automation, guidance, and seamless execution, announces today its double victory alongside esteemed partner Moderna< ...
Moderna: FDA Extends RSV Vaccine Review, But No Issues Flagged
Morningstar· 6 days agoModerna on Friday said the Food and Drug Administration won't meet its May 12 target action date for a decision on the company's proposed vaccine for respiratory syncytial ...
US FDA pushes decision on Moderna’s RSV vaccine to end of this month
WHTC 1450 Holland· 6 days ago(Reuters) - The U.S. Food and Drug Administration has pushed back its decision on Moderna's...